Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.

Chen L, Ho DW, Lee NP, Sun S, Lam B, Wong KF, Yi X, Lau GK, Ng EW, Poon TC, Lai PB, Cai Z, Peng J, Leng X, Poon RT, Luk JM.

Ann Surg Oncol. 2010 Sep;17(9):2518-25. doi: 10.1245/s10434-010-1038-8. Epub 2010 Mar 31.

2.

Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.

Hao K, Luk JM, Lee NP, Mao M, Zhang C, Ferguson MD, Lamb J, Dai H, Ng IO, Sham PC, Poon RT.

BMC Cancer. 2009 Nov 3;9:389. doi: 10.1186/1471-2407-9-389.

3.

Fucosylated glycan inhibition of human hepatocellular carcinoma cell migration through binding to chemokine receptors.

Wu LH, Shi BZ, Zhao QL, Wu XZ.

Glycobiology. 2010 Feb;20(2):215-23. doi: 10.1093/glycob/cwp168. Epub 2009 Nov 1.

PMID:
19884117
4.

Mass spectrometric study of N-glycans from serum of woodchucks with liver cancer.

Lattová E, McKenzie EJ, Gruwel ML, Spicer V, Goldman R, Perreault H.

Rapid Commun Mass Spectrom. 2009 Sep;23(18):2983-95. doi: 10.1002/rcm.4202.

PMID:
19685473
5.

New development of glycan arrays.

Wu CY, Liang PH, Wong CH.

Org Biomol Chem. 2009 Jun 7;7(11):2247-54. doi: 10.1039/b902510n. Epub 2009 Apr 27.

PMID:
19462030
6.

Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines.

de Leoz ML, An HJ, Kronewitter S, Kim J, Beecroft S, Vinall R, Miyamoto S, de Vere White R, Lam KS, Lebrilla C.

Dis Markers. 2008;25(4-5):243-58.

7.

Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer.

Wang CC, Huang YL, Ren CT, Lin CW, Hung JT, Yu JC, Yu AL, Wu CY, Wong CH.

Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11661-6. doi: 10.1073/pnas.0804923105. Epub 2008 Aug 8.

8.

Glycan arrays on aluminum-coated glass slides.

Tseng SY, Wang CC, Lin CW, Chen CL, Yu WY, Chen CH, Wu CY, Wong CH.

Chem Asian J. 2008 Sep 1;3(8-9):1395-405. doi: 10.1002/asia.200800154.

PMID:
18683161
9.

Diagnosis and treatment of hepatocellular carcinoma.

El-Serag HB, Marrero JA, Rudolph L, Reddy KR.

Gastroenterology. 2008 May;134(6):1752-63. doi: 10.1053/j.gastro.2008.02.090. Review.

PMID:
18471552
10.

Biology of hepatocellular carcinoma.

Pang RW, Joh JW, Johnson PJ, Monden M, Pawlik TM, Poon RT.

Ann Surg Oncol. 2008 Apr;15(4):962-71. doi: 10.1245/s10434-007-9730-z. Epub 2008 Jan 31. Review.

PMID:
18236113
11.

Hepatocellular carcinoma and sex.

Wands J.

N Engl J Med. 2007 Nov 8;357(19):1974-6. No abstract available.

PMID:
17989393
12.

Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.

Yi X, Luk JM, Lee NP, Peng J, Leng X, Guan XY, Lau GK, Beretta L, Fan ST.

Mol Cell Proteomics. 2008 Feb;7(2):315-25. Epub 2007 Oct 14.

13.

The current management of HBV drug resistance.

Liaw YF.

J Clin Virol. 2005 Dec;34 Suppl 1:S143-6. Review.

PMID:
16461216
14.
15.

Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen.

Huang CY, Thayer DA, Chang AY, Best MD, Hoffmann J, Head S, Wong CH.

Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):15-20. Epub 2005 Dec 22.

16.

Management of hepatocellular carcinoma.

Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases.

Hepatology. 2005 Nov;42(5):1208-36. No abstract available.

PMID:
16250051
17.

Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities.

Ouerfelli O, Warren JD, Wilson RM, Danishefsky SJ.

Expert Rev Vaccines. 2005 Oct;4(5):677-85. Review.

PMID:
16221069
18.

GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.

Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM.

J Hepatol. 2005 Dec;43(6):1007-12. Epub 2005 Jun 28.

PMID:
16137783
19.

Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.

Liaw YF.

Semin Liver Dis. 2005;25 Suppl 1:40-7. Review.

PMID:
16103980
20.

Supplemental Content

Support Center